PARNAX LAB
Back to Cashflow Statement
|
PARNAX LAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹8.18 Cr | ₹-16 Cr | ₹15 Cr | ₹-14 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of PARNAX LAB ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹8.18 Cr |
| Mar2025 | ₹-16 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹-14 Cr |
| Mar2022 | ₹12 Cr |
How is Cash Flow from Financing Activities of PARNAX LAB Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.18 Cr | Positive | |
| Mar2025 | ₹-16 Cr | Negative | |
| Mar2024 | ₹15 Cr | Positive | |
| Mar2023 | ₹-14 Cr | Negative | |
| Mar2022 | ₹12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PARNAX LAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PARNAX LAB | ₹133.3 Cr | 9.1% | 7.9% | -9.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
PARNAX LAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PARNAX LAB | 9.1% |
7.9% |
-9.3% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses